Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual.
Serena FasanoAntonella RiccardiValentina MessinitiPaola CaramaschiEdoardo RosatoBritta MaurerVanessa SmithElise SiegertEllen De LangheValeria RiccieriPaolo AiróCarina MihaiJerome AvouacElisabetta ZanattaUlrich A WalkerFlorenzo IannonePaloma García De la Peña LefebvreJörg H W DistlerAlessandra VaccaOliver DistlerOtylia Kowal-BieleckaYannick AllanoreGabriele ValentiniPublished in: Annals of the rheumatic diseases (2019)
The adjusted mean EUSTAR-AI has the best predictive value for disease progression and development of severe organ involvement over time in SSc.